Browse by category

FDA Approves IDE study assessing Revita for weight maintenance after discontinuation of GLP-1

The FDA has approved a pivotal Investigational Device Exemption (IDE) to study the efficacy of Fractyl Health’s Revita system for...

Journal Watch 8/1/2024

6 hours ago

Biomea Fusion announces first data on icovamenib-semaglutide combination study

11 hours ago

MBX Biosciences announces positive phase 1 topline results for MBX 1416 for the treatment of PBH

11 hours ago

Weekly Digest